Literature DB >> 35309105

Application of berberine-loaded albumin nanoparticles in infections of traumatic wounds.

Zhenqiang Liu1, Yanchao Liu2, Ting Fang3, Jianhua Xia4, Ning Ma5, Yanhong Wang1.   

Abstract

In recent years, the morbidity of infections in traumatic wounds has been on the increase. There are not many kinds of drugs for clinical treatment of infections, and their efficacy and safety are limited. Plant antimicrobial drugs are increasingly popular in mainstream medicine due to the challenges of traditional antibiotics abuse. Berberine has a scavenging effect on infections, however, berberine was restricted from using as a drug preparation with poor stability and bioavailability. Due to the low toxicity of nanoparticles, the green-synthetic, size-controlled approach of nanoparticles has been paid more attention. Therefore, based on the intermolecular disulfide bond network platform built earlier, we designed and developed a strategy to assemble molecular bovine serum albumin into large-sized nanostructures through the reconstructed intermolecular disulfide bond and hydrophobic interaction, and berberine with poor water solubility was encapsulated in it. Nanoassembly with bovine serum albumin increased biostability of berberine and significantly improved its activity against Staphylococcus Aureus (S.aureus) activity, which gives some new insights into the preparation and development of anti-infectives for Chinese medicine. IJBT
Copyright © 2022.

Entities:  

Keywords:  Infections; albumin nanoparticles; berberine; green-synthetic

Year:  2022        PMID: 35309105      PMCID: PMC8918763     

Source DB:  PubMed          Journal:  Int J Burns Trauma        ISSN: 2160-2026


  27 in total

Review 1.  The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data.

Authors:  M Malone; T Bjarnsholt; A J McBain; G A James; P Stoodley; D Leaper; M Tachi; G Schultz; T Swanson; R D Wolcott
Journal:  J Wound Care       Date:  2017-01-02       Impact factor: 2.072

Review 2.  The antifungal pipeline: a reality check.

Authors:  John R Perfect
Journal:  Nat Rev Drug Discov       Date:  2017-05-12       Impact factor: 84.694

3.  pH-Triggered release of an antifungal agent from polyglycidol-based nanoparticles against fuel fungus H. resinae.

Authors:  Mehdi Neqal; Joanne Fernandez; Véronique Coma; Mario Gauthier; Valérie Héroguez
Journal:  J Colloid Interface Sci       Date:  2018-04-21       Impact factor: 8.128

4.  Screening of isoquinoline alkaloids and their derivatives for antibacterial and antifungal activities.

Authors:  I L Tsai; Y F Liou; S T Lu
Journal:  Gaoxiong Yi Xue Ke Xue Za Zhi       Date:  1989-03

5.  BSA-modified poly(pyrrole-3-carboxylic acid) nanoparticles as carriers for combined chemo-photothermal therapy.

Authors:  Xuexin Bi; Huiling Su; Wei Shi; Xin Liu; Zi He; Xiuming Zhang; Yanan Sun; Dongtao Ge
Journal:  J Mater Chem B       Date:  2018-11-14       Impact factor: 6.331

6.  Self-Templated, Green-Synthetic, Size-Controlled Protein Nanoassembly as a Robust Nanoplatform for Biomedical Application.

Authors:  Ya Wen; Haiqing Dong; Kun Wang; Yan Li; Yongyong Li
Journal:  ACS Appl Mater Interfaces       Date:  2018-04-02       Impact factor: 9.229

7.  Staphylococcus epidermidis saeR is an effector of anaerobic growth and a mediator of acute inflammation.

Authors:  L D Handke; K L Rogers; M E Olson; G A Somerville; T J Jerrells; M E Rupp; P M Dunman; P D Fey
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

8.  Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.

Authors:  Maofan Zhang; C Tilden Hagan; Yuangzeng Min; Hayley Foley; Xi Tian; Feifei Yang; Yu Mi; Kin Man Au; Yusra Medik; Kyle Roche; Kyle Wagner; Zachary Rodgers; Andrew Z Wang
Journal:  Biomaterials       Date:  2018-03-31       Impact factor: 12.479

9.  Antibacterial, antifungal and cytotoxic isoquinoline alkaloids from Litsea cubeba.

Authors:  Wei Zhang; Jin-Feng Hu; Wen-Wen Lv; Qing-Chun Zhao; Guo-Bing Shi
Journal:  Molecules       Date:  2012-11-01       Impact factor: 4.411

10.  cRGDyK modified pH responsive nanoparticles for specific intracellular delivery of doxorubicin.

Authors:  Lipeng Qiu; Qing Hu; Liang Cheng; Ling Li; Chenmin Tian; Wei Chen; Qing Chen; Wen Hu; Lu Xu; Jia Yang; Lifang Cheng; Dawei Chen
Journal:  Acta Biomater       Date:  2015-11-19       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.